No abstract available
Keywords:
LLU, lower limb ulcer; NA, Necrotic angiodermatitis; RP, Raynaud's phenomenon; Raynaud's phenomenon; SSc, systemic sclerosis; arteriopathy; botulinum toxin (botox); calcinosis; connective tissue disease; lower limb ulcers; lymphangiopathy; macroangiopathy; microangiopathy; naifold videocapillaroscopy; systemic sclerosis; venous insufficiency.
PubMed Disclaimer
Conflict of interest statement
References
-
-
Blagojevic J., Piemonte G., Benelli L., et al. Assessment, definition, and classification of lower limb ulcers in systemic sclerosis: a challenge for the rheumatologist. J Rheumatol. 2016;43(3):592–598. doi: 10.3899/jrheum.150035.
-
DOI
-
PubMed
-
-
Hafner J., Nobbe S., Partsch H., et al. Martorell hypertensive ischemic leg ulcer: a model of ischemic subcutaneous arteriolosclerosis. Arch Dermatol. 2010;146(9):961–968. doi: 10.1001/archdermatol.2010.224.
-
DOI
-
PubMed
-
-
Shanmugam V.K., Price P., Attinger C.E., Steen V.D. Lower extremity ulcers in systemic sclerosis: features and response to therapy. Int J Rheumatol. 2010;2010 doi: 10.1155/2010/747946.
-
DOI
-
PMC
-
PubMed
-
-
Belch J., Carlizza A., Carpentier P.H., et al. ESVM guidelines - the diagnosis and management of Raynaud's phenomenon. Vasa. 2017;46(6):413–423. doi: 10.1024/0301-1526/a000661.
-
DOI
-
PubMed
-
-
Jerjen R., Nikpour M., Krieg T., Denton C.P., Saracino A.M. Systemic sclerosis in adults. Part II: Management and therapeutics. J Am Acad Dermatol. 2022 doi: 10.1016/j.jaad.2021.10.066. S0190-9622(22)00191-8.
-
DOI
-
PubMed